TGF-β Signaling Regulates Neuronal C1q Expression and Developmental Synaptic Refinement

Similar documents
Supplementary Figure 1. Microglia do not show signs of classical immune activation following MD a-b. Images showing immunoreactivity for MHCII (a)

Supplementary Table 1. List of primers used in this study

Supplemental Information. Menin Deficiency Leads to Depressive-like. Behaviors in Mice by Modulating. Astrocyte-Mediated Neuroinflammation

SUPPLEMENTARY INFORMATION

Supplementary Figure 1

GFP/Iba1/GFAP. Brain. Liver. Kidney. Lung. Hoechst/Iba1/TLR9!

SUPPLEMENTARY INFORMATION

Supplementary Figures

Supplementary Figure 1

Disrupting GluA2-GAPDH Interaction Affects Axon and Dendrite Development

Supplemental Figure 1. Western blot analysis indicated that MIF was detected in the fractions of

Structural basis for the role of inhibition in facilitating adult brain plasticity

SUPPLEMENTARY INFORMATION

CD31 5'-AGA GAC GGT CTT GTC GCA GT-3' 5 ' -TAC TGG GCT TCG AGA GCA GT-3'

Nature Neuroscience: doi: /nn.2275

Concerted action of CB1 cannabinoid receptor and Deleted in Colorectal Cancer (DCC) in axon guidance

Nature Neuroscience: doi: /nn Supplementary Figure 1

Supplemental Information. Otic Mesenchyme Cells Regulate. Spiral Ganglion Axon Fasciculation. through a Pou3f4/EphA4 Signaling Pathway

Supplementary Materials for. c-abl Activation Plays a Role in α-synucleinopathy Induced Neurodegeneration

SUPPLEMENTARY INFORMATION

marker. DAPI labels nuclei. Flies were 20 days old. Scale bar is 5 µm. Ctrl is

Supplementary Figure 1 IMQ-Induced Mouse Model of Psoriasis. IMQ cream was

(A) RT-PCR for components of the Shh/Gli pathway in normal fetus cell (MRC-5) and a

Supplementary fig. 1. Crystals induce necroptosis does not involve caspases, TNF receptor or NLRP3. A. Mouse tubular epithelial cells were pretreated

Supplementary Figure 1

Hypothalamic TLR2 triggers sickness behavior via a microglia-neuronal axis

Endocannabinoid-activated Nlrp3 inflammasome in infiltrating macrophages mediates β- cell loss in type 2 diabetes

Supplementary Information

Zhu et al, page 1. Supplementary Figures

SUPPLEMENTARY INFORMATION

ROCK/Cdc42-mediated microglial motility and gliapse formation lead to phagocytosis of degenerating dopaminergic neurons in vivo

SUPPLEMENTARY FIGURES

Rescue of mutant rhodopsin traffic by metformin-induced AMPK activation accelerates photoreceptor degeneration Athanasiou et al

well for 2 h at rt. Each dot represents an individual mouse and bar is the mean ±

SHREE ET AL, SUPPLEMENTAL MATERIALS. (A) Workflow for tumor cell line derivation and orthotopic implantation.

Supplemental Table 1. Primers used for RT-PCR analysis of inflammatory cytokines Gene Primer Sequence

Supplementary Figure 1: STAT3 suppresses Kras-induced lung tumorigenesis

mm Distance (mm)

Supplementary Figure 1. SybII and Ceb are sorted to distinct vesicle populations in astrocytes. Nature Neuroscience: doi: /nn.

M2 microglia/ macrophages drive oligodendrocyte differentiation during CNS remyelination

Endogenous TNFα orchestrates the trafficking of neutrophils into and within lymphatic vessels during acute inflammation

Supplementary Figure 1: TSLP receptor skin expression in dcssc. A: Healthy control (HC) skin with TSLP receptor expression in brown (10x

Supplementary Figure 1. EC-specific Deletion of Snail1 Does Not Affect EC Apoptosis. (a,b) Cryo-sections of WT (a) and Snail1 LOF (b) embryos at

Supplementary Figure 1: Hsp60 / IEC mice are embryonically lethal (A) Light microscopic pictures show mouse embryos at developmental stage E12.

Nature Biotechnology: doi: /nbt Supplementary Figure 1. Analysis of hair bundle morphology in Ush1c c.216g>a mice at P18 by SEM.

Supplementary Figure 1. IDH1 and IDH2 mutation site sequences on WHO grade III

c Ischemia (30 min) Reperfusion (8 w) Supplementary Figure bp 300 bp Ischemia (30 min) Reperfusion (4 h) Dox 20 mg/kg i.p.

Supplementary Figure S1. Monolayer differentiation of mouse ESCs into telencephalic neural precursors. (a) Schematic representation of the protocols

SUPPLEMENTARY FIG. S2. Representative counting fields used in quantification of the in vitro neural differentiation of pattern of dnscs.

Chapter 2. Investigation into mir-346 Regulation of the nachr α5 Subunit

Supplementary Figure 1. Normal T lymphocyte populations in Dapk -/- mice. (a) Normal thymic development in Dapk -/- mice. Thymocytes from WT and Dapk

Figure S1. Reduction in glomerular mir-146a levels correlate with progression to higher albuminuria in diabetic patients.

Supplementary Figure 1

Award Number: W81XWH TITLE: Role of Adenosine Receptor A 2A in Traumatic Optic Neuropathies PRINCIPAL INVESTIGATOR: Gregory I.

Programmed necrosis, not apoptosis, is a key mediator of cell loss and DAMP-mediated inflammation in dsrna-induced retinal degeneration

effect on the upregulation of these cell surface markers. The mean peak fluorescence intensity

Postn MCM Smad2 fl/fl Postn MCM Smad3 fl/fl Postn MCM Smad2/3 fl/fl. Postn MCM. Tgfbr1/2 fl/fl TAC

Supplemental Figure 1. Signature gene expression in in vitro differentiated Th0, Th1, Th2, Th17 and Treg cells. (A) Naïve CD4 + T cells were cultured

Supplementary Figure 1. BMS enhances human T cell activation in vitro in a

Social deficits in Shank3-deficient mouse models of autism are rescued by histone deacetylase (HDAC) inhibition

Myelin suppresses axon regeneration by PIR-B/SHPmediated inhibition of Trk activity

Title: Smooth muscle cell-specific Tgfbr1 deficiency promotes aortic aneurysm formation by stimulating multiple signaling events

Supplementary Materials for

Cells and reagents. Synaptopodin knockdown (1) and dynamin knockdown (2)

Supplementary information. The proton-sensing G protein-coupled receptor T-cell death-associated gene 8

Supplementary. limb. bars

Supplementary Figure 1. Prevalence of U539C and G540A nucleotide and E172K amino acid substitutions among H9N2 viruses. Full-length H9N2 NS

Supplemental Figure 1. (A) Western blot for the expression of RIPK1 in HK-2 cells treated with or without LPS (1 µg/ml) for indicated times.

SUPPLEMENTARY DATA. Supplementary Table 2. Antibodies used for Immunofluoresence. Supplementary Table 3. Real-time PCR primer sequences.

mir-7a regulation of Pax6 in neural stem cells controls the spatial origin of forebrain dopaminergic neurons

Supplementary information Novel VCP modulators mi2gate major pathologies of rd10, a mouse model of re2ni2s pigmentosa

Supplemental Figures:

Supplementary Figure S1. Venn diagram analysis of mrna microarray data and mirna target analysis. (a) Western blot analysis of T lymphoblasts (CLS)

Supplemental Table 1: Demographics and characteristics of study participants. Male, n (%) 3 (20%) 6 (50%) Age, years [mean ± SD] 33.3 ± ± 9.

Supplementary Figure 1. AdipoR1 silencing and overexpression controls. (a) Representative blots (upper and lower panels) showing the AdipoR1 protein

Supplementary Fig. S1. Schematic diagram of minigenome segments.

Bone marrow-derived mesenchymal stem cells improve diabetes-induced cognitive impairment by

Cell isolation. Spleen and lymph nodes (axillary, inguinal) were removed from mice

Supplementary Figure 1.TRIM33 binds β-catenin in the nucleus. a & b, Co-IP of endogenous TRIM33 with β-catenin in HT-29 cells (a) and HEK 293T cells

SUPPLEMENTARY INFORMATION

Nature Structural & Molecular Biology: doi: /nsmb Supplementary Figure 1. Generation and validation of mtef4-knockout mice.

An unconventional role for mirna: let-7 activates Toll-like receptor 7 and causes neurodegeneration

Supplementary Figure 1. Deletion of Smad3 prevents B16F10 melanoma invasion and metastasis in a mouse s.c. tumor model.

Supplementary Figure 1. Nature Neuroscience: doi: /nn.4547

Nature Medicine: doi: /nm.4324

Supplementary Figure 1: Validation of labeling specificity of immature OSNs and presynaptic terminals. (A) (B) (C) (D) (E)

Supplementary Figure 1. Expression of CUGBP1 in non-parenchymal liver cells treated with TGF-β

Fig. S1. Upregulation of K18 and K14 mrna levels during ectoderm specification of hescs. Quantitative real-time PCR analysis of mrna levels of OCT4

condition. Left panel, the HCT-116 cells were lysed with RIPA buffer containing 0.1%

Supplementary Figure 1: Co-localization of reconstituted L-PTC and dendritic cells

Supplementary Figure 1.

!! INL!!!! ONL!! IS/OS!!

sequences of a styx mutant reveals a T to A transversion in the donor splice site of intron 5

Supplementary Information Epigenetic modulation of inflammation and synaptic plasticity promotes resilience against stress in mice

Supplemental Figure 1. Characterization of CNS lysosomal pathology in 2-month-old IDS-deficient mice. (A) Measurement of IDS activity in brain

(a) Significant biological processes (upper panel) and disease biomarkers (lower panel)

Nature Neuroscience: doi: /nn Supplementary Figure 1. ACx plasticity is required for fear conditioning.

Comparison of open chromatin regions between dentate granule cells and other tissues and neural cell types.

B-cell. Astrocyte SCI SCI. T-cell

Supplementary Figure 1 Expression of Crb3 in mouse sciatic nerve: biochemical analysis (a) Schematic of Crb3 isoforms, ERLI and CLPI, indicating the

Transcription:

Supplementary Information Title: TGF-β Signaling Regulates Neuronal C1q Expression and Developmental Synaptic Refinement Authors: Allison R. Bialas and Beth Stevens

Supplemental Figure 1. In vitro characterization of cytokine or ACM-induced C1q upregulation. (A) C1r and c1s, the two genes that associate with C1q to form the C1 complex, are also significantly upregulated at 15 min by qpcr (one-way ANOVA, n=3 experiments, **p<0.01, ***p<0.001, F(1,8)=73.29). (B) A transcriptional inhibitor, actinomycin, blocks C1q upregulation, supporting that C1q upregulation is a transcriptional event (two-way ANOVA, n= 3 experiments, ***p<0.001, F(1,8)=4949.46). (C) Boiled ACM does not upregulate C1q, suggesting that a protein in ACM upregulates C1q (two-way ANOVA, n=3 experiments, ***p<0.001, F(1,8)=18.53). (D) IL-12 concentration response curve showed that RGCs did not upregulate C1q significantly (after 15 min. treatment) at any concentration tested (two-way ANOVA, n=3 samples per treatment, **p<0.01, *p<0.05, F(5,12)=14.75). (E) CXCL1 failed to upregulate C1q in RGCs (after 15 min. treatment) at any concentration tested (two-way ANOVA, n=3 samples per treatment, ***p<0.001, F(5,12)=11.06). (F) RT-PCR analysis of c1qa and c1qb expression shows a robust upregulation of C1q by insert (I) versus control (C), while IL-6 or TNFα treatment induces a modest increase in C1q. (G) TGF-β3 mrna is enriched in retinal astrocytes compared to other astrocytes (McCarthy and de Vellis (MD) preparation and purified cortical astrocytes (cortical), RGCs, and microglia (Mg) (two-way ANOVA, n=3 experiments, ***p<0.001, F(8,45)=15.88).

Supplemental Figure 2. Validation of retinal TGFβRII -/- mouse (A) C1q immunostaining is developmentally regulated in the IPL and RGC retinal layers. Scale bar = 20µm. (B) Colocalization of TGFβRII and calretinin by immunohistochemistry indicates that TGFβRII is expressed on RGCs in vivo. Scale bar = 20µm. (C) RT-PCR using RNA from P5 whole brain lysates from retinal TGFβRII -/- and WT littermates shows no difference in tgfbr2 expression. (D) Validation that a known TGF-β-dependent gene, TIEG, is downregulated in the retinal TGFβRII -/- mouse and when anti-tgf-β is injected into the eye (one-way ANOVA, n=3 samples/group, **p<0.01, ***p<0.001, F(3,8)=27.93). (E) Whole mount retina immunostaining for Tuj1 shows no difference in the number of RGCs in TGFβRII retinal KO mice vs. WT littermates. (t test, n=4 mice/group, p=0.4040 no significance, t(6)=0.897539). Scale bar =30µm. (F) Immunohistochemistry with anti-βiv spectrin to mark axon initial segments showed similar numbers in WT and retinal TGFβRII -/- retinas. Scale bar = 30µm. Bottom panel: Axon density was measured by counting the number of fascicles (labeled by intraocular injection of CTB conjugated to Alexa 488) in the nerve/area of the optic nerve cross section. (G) Axon initial segment density was determined by measuring the area of axons/area of the field. Density was measures for 10 fields of view per mouse and normalized to WT (t test, n=3 mice, p=0.2993 (ns), t(4)=1.192). (H) Quantification of axon density showed no difference between WT and retinal TGFβRII -/- mice (t test, n=3 mice, p=0.5575 (ns), t(4)=0.6391).

Supplemental Figure 3. Blocking TGF-β signaling with anti-tgf-β reduces C1q expression levels. (A) In situ for c1qa shows expression of C1q in the RGC layer is significantly reduced in the retinal TGFβRII -/- mouse and shows a patchy reduction in anti-tgf-β injected mice. Scale bar =100µm. (B) RGCs acutely isolated from P5 WT saline injected (white bar) and anti-tgf-β injected (grey bar) mouse retinas using immunopanning showed a significant reduction in C1q expression (two-way ANOVA, n= 4 mice/group, *p<0.05, F(2,18)=7.108). Microglia acutely isolated using CD45 immunopanning show no difference in C1q levels. (C) Acutely isolated RGCs and microglia were checked for the expression of neuron specific and microglia specific genes, nse and iba1, respectively. RGCs were significantly enriched for nse compared to microglia and microglia were significantly enriched for iba1 compared to RGCs (two-way ANOVA, n=5 samples/group, **p<0.01,***p<0.001, F(1,16)=224.5). (D) Quantification of the relative fluorescence intensity in the IPL of anti-tgf-β injected and WT vehicle injected littermates shows a significant reduction in C1q localization to the IPL when TGF-β signaling is blocked (one-way ANOVA, n= 4 mice/group, *p<0.05, F(3,12)=6.306). Scale bar = 50µm. (E) Immunohistochemistry validation of C1q localization to RGCs and microglia as shown by C1q co-localization with markers for microglia (CD68) and RGCs (Calretinin). Co-localized cells indicated by arrows. Scale bar = 20µm. (F) Immunohistochemistry for C3 (Cappel, goat anti-c3) shows a reduction in C3 levels in the C1q -/- relative to WT littermate controls. Images shown are representative of 4 mice. Scale bar = 20µm.

Supplemental Figure 4. Microglia numbers and localization are unaffected in TGFβRII retinal KO mice. (A) Representative images stained for Iba1 show that microglia morphology and distribution are similar in WT, retinal TGFβRII -/-, and C1q -/- mice. Scale bar= 100µm. (B) Quantification of microglia density within the dlgn shows similar densities in WT, retinal TGFβRII - /-, and C1q -/- mice (one-way ANOVA, n= 4 animals/group, p=0.7849 (ns), F(2,9)=0.2489). Density was calculated as the number of microglia divided by the dlgn area, excluding optic tract. Numbers were normalized to WT. (C) Representative microglia from P5 dlgn showed similar activation states in WT, retinal TGFβRII -/-, and C1q -/- mice based on established activation state markers 7. (D) WT, retinal TGFβRII -/-, and C1q -/- mice showed a similar distribution of microglia activation state in the P5 dlgn. Microglia from two dlgn sections were sampled and immunostained for Iba1 (Dako) and CD68. (two-way ANOVA, n=4 mice/condition, p=0.6463 (ns), F(4,20)=0.63).

Supplemental Figure 5. Model of Complement-dependent Synapse Elimination. Our data and previous work support a model in which RGCs express C1q in response to TGF-β signaling and secrete C1q from their axon terminals in the dlgn. Once secreted, C1q localizes to inappropriate synapses where it triggers the classical complement cascade. C3 becomes activated and binds to inappropriate synapses, recruiting phagocytic microglia, expressing CR3, to remove inappropriate synapses by engulfment 7. Microglia preferentially engulf less active retinogeniculate inputs (red axon) 7 ; however it is not yet known whether or how complement targets weak inputs for elimination or if other mechanisms protect the specific (ie. stronger) synaptic inputs from elimination.

Supplemental Figure 6. Full-length pictures of the blots presented in the main figures. (A) Fig. 1d (B) Fig.3a (C) Fig. 3b (D) Fig. 2i (E) Fig. 3e